Home/Injections/Cinacort Injection

No image available

Cinacort Injection

Cinacort Injection, containing 40 mg of triamcinolone acetonide in a water for injection (WFI) solution, is a potent corticosteroid formulation designed for pharmaceutical manufacturers and suppliers seeking reliable, high-quality injectable corticosteroids for global markets.

Composition

Triamcinolone Acetonide 40 mg Inj.

Pack Size

1 vial with WFI

Category

Injections

Cinacort Injection is a sterile, aqueous solution of triamcinolone acetonide, a long-acting glucocorticoid with potent anti-inflammatory, immunosuppressive, and anti-proliferative properties. The formulation is designed for injectable use, with triamcinolone acetonide dissolved in WFI to ensure stability, compatibility, and optimal pharmacokinetic performance. The product’s composition is optimized for pharmaceutical manufacturing, ensuring consistent potency, clarity, and absence of particulate matter. The excipient profile, which includes WFI as the primary solvent, supports compatibility with various administration routes while maintaining sterility and chemical stability under standard storage conditions. The formulation is engineered to meet stringent pharmaceutical specifications, including pH, osmolarity, and endotoxin limits, ensuring suitability for use in diverse therapeutic applications.

Manufacturing Capability

Our manufacturing infrastructure is equipped to produce Cinacort Injection at scale, leveraging state-of-the-art facilities compliant with current Good Manufacturing Practices (cGMP). The production process employs advanced aseptic techniques, including ISO Class 7 cleanroom environments, to ensure sterility and contamination control. The facility is designed for full scalability, enabling seamless transitions from small-scale development to large-volume commercial production. Key capabilities include automated vial filling, sealing, and labeling systems, as well as rigorous process validation to ensure consistency and reproducibility. Quality systems are integrated throughout the manufacturing workflow, with real-time monitoring and traceability protocols to meet regulatory requirements. The facility also supports customization for specialized packaging and labeling, ensuring flexibility to meet diverse market demands.

Available Strengths and Packaging

Cinacort Injection is available in a single strength of 40 mg per vial, formulated in water for injection (WFI) to ensure compatibility with injectable delivery systems. The packaging consists of a single vial sealed with WFI, designed for stability during storage and transport. This standardized packaging ensures ease of use, compliance with pharmaceutical specifications, and suitability for both domestic and international distribution.

Contract Manufacturing / Third Party Manufacturing

As a trusted manufacturer, we offer comprehensive contract manufacturing and third-party production services tailored to pharmaceutical buyers. Our capabilities include private label manufacturing, where we produce under a client’s brand name, as well as contract manufacturing for OEM and ODM requirements. We support full-service solutions, from API sourcing and formulation development to packaging and labeling, ensuring end-to-end compliance with global regulatory standards. Our team specializes in producing injectable corticosteroids like Cinacort Injection, with expertise in scaling production to meet bulk supply demands. Whether you require customized packaging, specialized formulation adjustments, or regulatory support, our flexible manufacturing infrastructure ensures timely delivery of high-quality products.

Quality Assurance

Our quality assurance systems are designed to ensure consistency, safety, and compliance throughout the production lifecycle of Cinacort Injection. Each batch undergoes rigorous testing, including potency analysis, sterility testing, and endotoxin detection, using validated methods such as HPLC and microbial limit tests. Analytical validation ensures accuracy in determining triamcinolone acetonide concentration, while stability studies confirm shelf life under specified conditions. Quality control protocols are aligned with international standards, including USP, EP, and BP, to guarantee product integrity. Comprehensive documentation, including batch records and deviation reports, is maintained for audit readiness. Our commitment to quality extends to raw material sourcing, with suppliers vetted for compliance with cGMP and pharmacopeial standards.

Regulatory Compliance

Cinacort Injection is manufactured in full compliance with global regulatory frameworks, including cGMP, WHO guidelines, and ISO 9001 standards. Our facility adheres to stringent quality management systems, ensuring adherence to pharmacopeial requirements for sterility, potency, and purity. Products are validated for compliance with international pharmacopoeias, enabling seamless regulatory approval in target markets. We maintain detailed documentation for audits, including batch-specific records, validation reports, and deviation investigations. Our regulatory expertise extends to supporting clients with submissions to agencies such as the FDA, EMA, and WHO, ensuring alignment with global standards for pharmaceutical manufacturing.

Global Supply Capability

We provide robust global supply capabilities, with a well-established international distribution network and bulk supply capacity to meet the demands of pharmaceutical distributors and exporters. Our export infrastructure supports compliance with international shipping regulations, including IATA and IMDG standards, ensuring safe and timely delivery to over 150 countries. The facility is equipped for large-scale production, enabling bulk supply to meet regional and global market needs. Our supply chain is designed for reliability, with redundant logistics partnerships and real-time tracking systems to minimize delays. We prioritize supply chain resilience, ensuring consistent availability of Cinacort Injection for clients worldwide.

Why Choose Us

Pharmaceutical distributors, exporters, and contract manufacturing partners select us for our expertise in injectable corticosteroid production, compliance with global standards, and scalable manufacturing capabilities. Our commitment to quality, combined with a proven track record in bulk supply and regulatory support, positions us as a reliable partner for pharmaceutical buyers. We offer tailored solutions to meet specific market requirements, from customized packaging to regulatory assistance, ensuring seamless integration into your supply chain. Our team of specialists provides end-to-end support, from formulation development to global distribution, enabling you to focus on growth while we ensure operational excellence.

Bulk Supply Inquiry

For bulk supply inquiries or to discuss customized manufacturing requirements, please contact us at info@delwishealthcare.com. Our team is dedicated to delivering high-quality, compliant pharmaceutical products to meet your business needs.

FAQs

  1. What is the manufacturing process for Cinacort Injection?

    Cinacort Injection is produced using aseptic manufacturing techniques in ISO Class 7 cleanrooms, ensuring sterility and compliance with cGMP standards.

  2. What packaging options are available for Cinacort Injection?

    The product is available in 1 vial with water for injection (WFI), designed for stability and ease of use in injectable applications.

  3. Can Cinacort Injection be customized for specific markets?

    Yes, we offer private label manufacturing and customized packaging solutions to meet regional regulatory and market requirements.

  4. What regulatory standards does Cinacort Injection comply with?

    The product adheres to cGMP, WHO guidelines, ISO 9001, and pharmacopeial standards (USP, EP, BP) for global market access.

  5. Is bulk supply available for Cinacort Injection?

    Yes, we provide bulk supply capabilities to meet the demands of pharmaceutical distributors and exporters worldwide.

  6. How is quality ensured during production?

    Each batch undergoes rigorous testing, including sterility, potency, and endotoxin analysis, with full documentation for audit compliance.

  7. What is the shelf life of Cinacort Injection?

    The product has a shelf life of 24 months when stored under recommended conditions (2–8°C), as validated by stability studies.

  8. Can you support export to specific regions?

    Yes, our global distribution network enables export to over 150 countries, with compliance to IATA and IMDG shipping regulations.

  9. What is the minimum order quantity for bulk supply?

    Minimum order quantities are flexible and tailored to client requirements, with options for small-scale trials or large-volume production.

  10. How can I initiate a bulk supply inquiry?

    Contact our team at **info@delwishealthcare.com** to discuss your requirements and receive a customized quotation.

Enquire About This Product

Fill in your details and our team will contact you with more information.

No form fields available.

Need More Information?

Our team is ready to assist you with any questions about Cinacort Injection

Contact Us